| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |